The role of epigenetics in the development of metabolic diseases: A biochemical perspective

Read full text Summarise with VIRAT
Authors: Markus Reinhardt, Katharina C. Engel
Cited by: 0
References: 14

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Can inherited patterns of gene regulation, rather than DNA sequence alone, determine who develops metabolic disease? This research examined epigenetic modifications-including DNA methylation, histone acetylation, and non-coding RNA expression-in patients with type 2 diabetes mellitus, obesity, non-alcoholic fatty liver disease, and metabolic syndrome across two German academic centers. We recruited 260 participants (142 from Munich, 118 from Heidelberg) between March 2021 and November 2022 and collected peripheral blood samples for genome-wide methylation profiling using Illumina EPIC arrays. Our results showed that promoter-region hypermethylation of PPARGC1A was present in 67.3% of the type 2 diabetes group compared to 12.3% of healthy controls (p

Fields of Study & Subjects

Epigenetics and DNA Methylation Birth Development and Health Genomics and Chromatin Dynamics

Publication details

Journal / source
International Journal of Advanced Biochemistry Research
Volume
10
Issue
1
Pages
77–81
Publication date
1 January 2026
Language
EN